Effect of Preoperative Antiplatelet or Anticoagulation Therapy on Hemorrhagic Complications in Patients with Traumatic Brain Injury Undergoing Craniotomy or Craniectomy
Overview
Affiliations
Objective: Traumatic brain injury (TBI) is common among the elderly, often treated with antiplatelet (AP) or anticoagulation (AC) therapy, creating new challenges in neurosurgery. In contrast to elective craniotomy, in which AP/AC therapy is mostly discontinued, in TBI usually no delay in treatment can be afforded. The aim of this study was to analyze the effect of AP/AC therapy on postoperative bleeding after craniotomy/craniectomy in TBI.
Methods: Postoperative bleeding rates in patients treated with AP/AC therapy (blood thinner group) and in those without AP/AC therapy (control group) were retrospectively compared. Furthermore, univariate and multivariate analyses were conducted to identify risk factors for postoperative bleeding. Lastly, a proportional Cox regression analysis comparing postoperative bleeding events within 14 days in both groups was performed.
Results: Of 143 consecutive patients undergoing craniotomy/craniectomy for TBI between 2012 and 2017, 47 (32.9%) were under AP/AC treatment. No significant difference for bleeding events was observed in univariate (40.4% blood thinner group vs 36.5% control group; p = 0.71) or Cox proportional regression analysis (log rank χ2 = 0.29, p = 0.59). Patients with postoperative bleeding showed a significantly higher mortality rate (p = 0.035). In the univariate analysis, hemispheric lesion, acute subdural hematoma, hematological disease, greater extent of midline shift, and pupillary difference were significantly associated with a higher risk of postoperative bleeding. However, in the multivariate regression analysis none of these factors showed a significant association with postoperative bleeding.
Conclusions: Patients treated with AP/AC therapy undergoing craniotomy/craniectomy due to TBI do not appear to have increased rates of postoperative bleeding. Once postoperative bleeding occurs, mortality rates rise significantly.
Grubel N, Klemptner C, Mayer B, Runck F, Durner G, Wirtz C Diagnostics (Basel). 2024; 14(22).
PMID: 39594160 PMC: 11592454. DOI: 10.3390/diagnostics14222494.
Outcome after decompressive craniectomy in older adults after traumatic brain injury.
Kapapa T, Jesuthasan S, Schiller F, Schiller F, Woischneck D, Grave S Front Med (Lausanne). 2024; 11:1422040.
PMID: 39040896 PMC: 11260794. DOI: 10.3389/fmed.2024.1422040.
The Impact of Aspirin in Brain Tumor Surgery: To Stop or Not to Stop?.
Kienzler J, Fandino J Cureus. 2024; 15(12):e51231.
PMID: 38283531 PMC: 10821756. DOI: 10.7759/cureus.51231.
Li G, Chen S, Han J, Pan W, Ji P Pak J Med Sci. 2023; 39(5):1296-1300.
PMID: 37680810 PMC: 10480711. DOI: 10.12669/pjms.39.5.7401.
The role of extended coagulation screening in adult cranial neurosurgery.
Wagner A, Wostrack M, Hartz F, Heim J, Hameister E, Hildebrandt M Brain Spine. 2023; 3:101756.
PMID: 37383462 PMC: 10293229. DOI: 10.1016/j.bas.2023.101756.